180 related articles for article (PubMed ID: 32155018)
1. Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma.
Fayne R; Nanda S; Nichols A; Shen J
J Drugs Dermatol; 2020 Feb; 19(2):202-204. PubMed ID: 32155018
[TBL] [Abstract][Full Text] [Related]
2. A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Nahm WJ; Shen J; Zito PM; Gonzalez AM; Nagrani N; Moore K; Badiavas EV; Kirsner RS; Nichols AJ
J Drugs Dermatol; 2021 Mar; 20(3):260-267. PubMed ID: 33683072
[TBL] [Abstract][Full Text] [Related]
3. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
Queen D; Trager MH; Fan W; Gordon ER; Samie FH
Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
[TBL] [Abstract][Full Text] [Related]
4. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Smith KJ; Germain M; Skelton H
Dermatol Surg; 2001 Jun; 27(6):561-4. PubMed ID: 11442593
[TBL] [Abstract][Full Text] [Related]
6. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
7. Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Ondo AL; Mings SM; Pestak RM; Shanler SD
J Am Acad Dermatol; 2006 Dec; 55(6):1092-4. PubMed ID: 17097406
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
Nahm W; Nichols A; Rapoport E; Kirsner R; Badiavas E; Wyant W; Arthur A; Shen J
J Drugs Dermatol; 2023 May; 22(5):486-490. PubMed ID: 37133482
[TBL] [Abstract][Full Text] [Related]
9. Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Donigan JM; Hyde MA; Goldgar DE; Hadley ML; Bowling M; Bowen GM
JAMA Dermatol; 2018 Aug; 154(8):885-889. PubMed ID: 29847610
[TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
11. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
12. Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery.
Pederson H; Staples CJ; Housewright C
J Drugs Dermatol; 2020 May; 19(5):485-486. PubMed ID: 32484617
[TBL] [Abstract][Full Text] [Related]
13. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L; Singh R; Grada A; Feldman S
J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
[TBL] [Abstract][Full Text] [Related]
14. Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report.
Ye JN; Rhew DC; Yip F; Edelstein L
Cutis; 2006 Apr; 77(4):245-50. PubMed ID: 16706242
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
Hyde MA; Hadley ML; Tristani-Firouzi P; Goldgar D; Bowen GM
Arch Dermatol; 2012 May; 148(5):592-6. PubMed ID: 22431716
[TBL] [Abstract][Full Text] [Related]
16. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
19. Novel Treatment of In-Transit Metastatic Melanoma With Shave Excision, Electrodesiccation and Curettage, and Topical Imiquimod 5% Cream.
Globerson JA; Nessel T; Basehore BM; Saleeby ER
J Drugs Dermatol; 2021 May; 20(5):555-557. PubMed ID: 33938702
[TBL] [Abstract][Full Text] [Related]
20. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Bahner JD; Bordeaux JS
Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
